Delivery Order SPE2DB24D2011-SPE2DB25FBRNV
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a firm fixed price delivery order from the Defense Logistics Agency's Medical Supply Chain for Otezla 30 mg tablets (60-count units) valued at $35,634.81. This non-set-aside, competitively awarded contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The order represents a standard pharmaceutical supply delivery executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,311.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $27,320.78. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $36,477.84 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Otezla 30 mg tablets (60-count units). The contract is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count) under a firm fixed price contract valued at $6,381.96, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $13,321.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count packages) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The pharmaceutical distributor, headquartered in...
- This delivery order, issued by the Defense Logistics Agency Medical Supply Chain on August 4, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at approximately $33.3K for the supply of Otezla 30 mg tablets (60-count units). The contract, which is not set-aside and was competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for supply of Otezla 30 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $48,488.62 with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,026.45 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 14, 2025, with a completion date of August 15, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract and is part of a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical contract SPE2DX valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $5,668.59 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Otezla 30 mg tablets (60-count units). This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRNVDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 13, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $60,644.38. The contract carries a firm fixed price structure with an ultimate completion date of August 14, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This award supports the Defense Logistics Agency's medical supply chain mission to provision the Department of Defense healthcare systems, including military treatment facilities and the Defense Health Agency. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a pharmaceutical prime vendor, supplying brand-name and generic medications across multiple therapeutic domains to support military healthcare requirements globally. The delivery order for Otezla, a prescription medication used to treat dermatological and rheumatologic conditions, reflects the company's ongoing capability to fulfill federal pharmaceutical procurement needs through its established prime vendor relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.6k | 8/13/25 |